Scientific Programme

The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community.

Sunday 28 October
Monday 29 October
Tuesday 30 October
Wednesday 31 October

Sunday 28 October

12:00–13:30Interactive Case Study Session
In collaboration with the University of Liverpool Drug Interactions website:
www.hiv-druginteractions.org

12.00–12.15HIV pharmacology in 2018
Saye Khoo, Molecular and Clinical Pharmacology, University of Liverpool, Liverpool,
UK

12.15–12.40Case 1: TB co-infection
Marta Boffito, HIV and Sexual Health – Kobler Clinic, Chelsea Westminster
Hospital, London, UK

12.40–13.05Case 2: HIV-HCV and PWIDS
Erica Peters, Brownlee Centre for Infectious Diseases, NHS Greater Glasgow
Clyde, Glasgow, UK

13.05–13.30Case 3: Pregnancy
Presenter:Mas Chaponda, Royal Liverpool and Broadgreen University Hospitals NHS
Trust, Liverpool, UK

Discussants: Fiona Marra, Advanced Pharmacist HIV/HCV, Gartnavel Hospital,
Glasgow, UK
Mohammed Lamorde, Infectious Diseases Institute, Makerere University,
Kampala, Uganda

Jonathan Schapiro, National Haemophilia Center,
Israel Sheba Medical Center, Tel Aviv, Israel

13:30–14:30Lunch

14:30–16:00Industry Symposium

16:00–16:30Coffee

16:30–16:40Official Opening
Andrew Phillips, University College London, London, UK

Welcome from Glasgow City
Representative from Glasgow City Council, Glasgow, UK

16:40–18:35Opening Scientific Session
Co-Chairs:Praphan Phanuphak, Thai Red Cross Research Centre, Bangkok, Thailand
Andrew Phillips

16:40–16:55Celebrating a Champion of the Response to HIV
Remembering David Cooper
Tribute by: Sean Emery, University of New South Wales, Sydney, Australia

16:55–17:35Joep Lange and Jacqueline van Tongeren Memorial Lecture: HIV/AIDS, global
health and the Sustainable Development Goals

Kevin M De Cock, CDC Country Office, Nairobi, Kenya
Lecture dedicated to Joep Lange and Jacqueline van Tongeren in recognition of
their commitment and passion to rid the world of HIV/AIDS

Introduction by: Praphan Phanuphak

17:35-18:05Strategies to reduce HIV incidence in Europe
Anastasia Pharris, European Centre for Disease Prevention and Control (ECDC),
Stockholm, Sweden

18:05-18:35PrEP: what’s happening in Europe and the World in general
Sheena McCormack, MRC Clinical Trials Unit at UCL, London, UK

18:35–19:30Welcome Reception

Back to the top of the page

Monday 29 October

08:30–10:10Living Well with HIV: Ongoing Challenges

08:30–08:50Retention and re-engagement in care: a combination approach again required
Fiona Burns, Centre for Sexual Heath and HIV Research,
and Royal Free Hospital, London, UK

08:50–09:10HIV and ageing: challenges and goals
Julian Falutz, Department of Medicine, McGill University, Montreal, Canada

09:10-09:25Oral Paper

09:25–09:40Oral Paper

09:40–09:55Oral Paper

09:55–10:10Oral Paper

10:10–10:30Discussion

10:30-11:00Coffee

11:00-11:10In Memory of Mark Wainberg
Mark made an enormous contribution to both the basic science and global
politics of the HIV epidemic. He was a president of the International AIDS
Society, received Canada’s highest civilian award and was an extremely active
member of the scientific committee of HIV Glasgow for over 20 years.
Tribute by: Ian Weller, University College London, London, UK

11:10–11:55Lock Lecture
HIV Glasgow is honoured to have been chosen by the Royal College of Physicians
and Surgeons of Glasgow to present the Lock Lecture as part of the Scientific
Programme

11:10-11:15Lock Lecture: introduction
David Galloway, President, Royal College of Physicians and Surgeons of Glasgow,
Glasgow, UK

11:15-11:55STIs among MSM: new challenges in prevention, diagnosis and treatment
Jean-Michel Molina, Department of Infectious Diseases and University of Paris 7,
St Louis Hospital, Paris, France

11:55-13:30Scientific Posters and Lunch

13:30-15:30Drug Interactions, ARV Toxicity and Switching

13:30–13:50The top 10 DDIs in day to day clinical management of HIV
Catia Marzolini, Division of Infectious Diseases & Hospital Epidemiology,
University Hospital Basel, Basel, Switzerland

13:50-14:10Adverse effects of current ARVs: myths and realities
Patrick Mallon, Mater Misericordiae University Hospital, Dublin

14:10-14:25Oral paper

14:25-14:40Oral paper

14:40-14:55Oral paper

14:55-15:10Oral paper

15:10-15:30Discussion

15:30–17:00Challenging Cases in HIV
In collaboration with the International Antiviral Society-USA (IAS-USA)

15.30–15.40Welcome and introduction
Carlos del Rio

15.40–16.05Case 1: ART: initiating treatment
Chloe Orkin, Ambrose King Centre, Royal London Hospital, London, UK

16.05–16.30Case 2: PrEP to PEP conversion
Roy M Gulick, Weill Cornell Medicine, New York, NY, USA

16.30–17.00Case 3: ART: treatment failure
Manuel Battegay, Division of Infectious Diseases and Hospital Epidemiology,
University Hospital Basel, Basel, Switzerland

Panel:Manuel Battegay
Carlos del Rio
Roy M Gulick
Chloe Orkin
Ian Williams

17:00–17:30Coffee

17:30–19:00Industry Symposium

Back to the top of the page

Tuesday 30 October

08:30–10:00Industry Symposium

10:00–10:30Coffee

10:30–12:30Approaches to Treatment and Cure

10:30-10:45Oral paper

10:45-11:00Oral paper

11:00-11:15Oral paper

11:15-11:30Oral paper

11:30–11:50Approaches towards a cure for HIV
Sarah Fidler, Department of GUM and HIV Medicine, Imperial College and
Imperial College NHS Trust, London UK

11:50–12:10HIV cure and cancer immunotherapy: cross-disciplinary research at its best
Steven G Deeks, Department of Medicine, University of California,
San Francisco, CA, USA 

12:10–12:30Discussion

12:30–14:00Scientific Posters and Lunch

12:45–13:45EATG Session 
In collaboration with the European AIDS Treatment Group (EATG)

14:00–15:30#Adolescent Lives Matter
In collaboration with the International AIDS Society (IAS)
Moderators:Yana Panfilova, Student, Academy of Labour, Social Work and
Tourism, Kiev, Ukraine, and HIV activist and founder of Teenergizer,
a youth movement
Linda-Gail Bekker, The Desmond Tutu HIV Centre, University of Cape
Town, Cape Town, South Africa, and Immediate Past-President, IAS

14:00-14:15Living with it: complications of long term HIV
Rashida Ferrand, London School of Hygiene and Tropical Medicine, London, UK, and
Harare, Zimbabwe 

14:15-14:30Taking it: PrEP experiences among adolescent MSM
Sybil Hosek, John Stroger Hospital of Cook Country, Chicago, IL, USA

14:30-14:45Staying with it: novel ways to increase adolescent adherence
Caroline Foster, Imperial College NHS Trust, London, UK

14:45-15:00Dealing with it: mental health and stigma: report from a cohort of YPLHIV
in the Ukraine

Heather Bailey, Population, Policy and Practice Programme, UCL Great Ormond Street
Institute of Child Health, London, UK 

15:00-15:15Adolescent friendly – really?
Mercy Ngulube, Chair, Children’s HIV Association’s Youth Committee, UK

15:15-15:30Discussion

15:30–17:00Mental Health and HIV: what we all need to know
In collaboration with the British HIV Association (BHIVA)
Co-Chair:Tamás Bereczky, European AIDS Treatment Group, Budapest, Hungary
Chloe Orkin, Ambrose King Centre, Royal London Hospital,
London, UK; and Chair, BHIVA

15:30–15:40BHIVA Mental Health Audit
Chloe Orkin

15:40–15:55Prevalence of mental health problems among people living with HIV 
Fiona Lampe, Infection & Population Health, University College London, London, UK

15:55–16:10Discrimination in EU healthcare: the community perspective 
Caroline Izambert, AIDES, Paris, France

16:10–16:25Important DDIs: to include QT/PR interval concerns
Laura Waters, Mortimer Market Centre, University College London Hospitals,
London, UK

16:25–16:40Managing insomnia 

16:40–17:00Q & A 
All

17:00–17:30Coffee

17:30–19:00Industry Symposium

19:00–19:45Poster reception

Back to the top of the page

Wednesday 31 October

08:30–08:50HIV and Migration: a renewed challenge

08:30–08:50HIV and migration: a renewed challenge
Julia Del Amo, National Center for Epidemiology, Institute of Health Carlos III,
Madrid, Spain

08:50-10:00 Co-infections: TB and Viral Hepatitis

08:50–09:10HIV-associated tuberculosis: diagnosis, management and prevention 
Graeme Meintjes, University of Cape Town, Cape Town, South Africa

09:10-09:30Eliminating hepatitis C: a public health perspective
Margaret Hellard, Burnet Institute, Melbourne, Australia; and Viral Hepatitis Services,
Department of Infectious Diseases, The Alfred Hospital Melbourne, Australia 

09:30–09:45Oral paper

09:45–10:00Oral paper

10:00-10:15Discussion

10:15–10:45Coffee

10:45–12:00What Women Want
Joint session in collaboration with the European AIDS Clinical Society (EACS) and
Women Against Viruses in Europe (WAVE)

Co-Chairs:Justyna D Kowalska, Hospital for Infectious Diseases, Medical
University of Warsaw, Warsaw, Poland
Fiona Mulcahy, Department of Genito-Urinary Medicine & Infectious
Diseases, St James’ Hospital, Dublin, Ireland

10:45–11:10PrEP for women in Europe: case presentation and lecture
Agnieszka Wroblewska, HIV Out-Patient CLinic, Hospital for Infectious Diseases,
Warsaw, Poland (Case) 

Nneka Nwokolo, Sexual Health and HIV Medicine, Chelsea and Westminster
Hospital, London, UK (Lecture)

11:10–11:35Pharmacokinetic studies in women and its impact on clinical practice: case
presentation and lecture  

Eugénie Colin-Benoit, Department of Infectious Diseases, University Hospital Bern,
Bern, Switzerland (Case)

Karoline Aebi-Popp, Department of Infectious Diseases, University Hospital Bern,
Bern, Switzerland (Lecture)

11:35–12:00HCV treatment and pregnancy: case presentation and lecture 
Marta Vasylyev, Out Patient Department, Lviv Regional AIDS Center,
Lviv, Ukraine (Case)

Karine Lacombe, Infectious and Tropical Diseases Department, Saint Antoine
Hospital (AP-HP), Paris, France (Lecture)

12:00–13:20Scientific Posters and Lunch

12:15–13:05Poster Discussions Sessions

12:15–13:05Poster Discussions Sessions

13:20–15:00Late Breakers/Hot Topics

13:20–13:45New ARV drugs and strategies
Alexandra Calmy, HIV/AIDS Unit, Geneva University Hospital, Geneva, Switzerland

13:45–14:00Oral paper

14:00–14:15Oral paper

14:15–14:30Oral paper

14:30–14:45Oral paper

14:45–15:00Oral paper

15:00–15:10Congress Closing Remarks
Giulio Corbelli, European AIDS Treatment Group (EATG), Brussels, Belgium and
Bologna, Italy

Andrew Phillips

Back to the top of the page